Olanzapine-induced Psoriasis

Olanzapine is a second-generation antipsychotic drug mainly used in the treatment of schizophrenia. It has several side effects including weight gain, hypercholesterolemia, and hyperglycemia, but dermatological side effects are rarely reported. We report a rare case of olanzapine-induced psoriasis.

Detalles Bibliográficos
Autores principales: Chepure, Ashish Hanmantrao, Ungratwar, Apurva Karmveer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733436/
https://www.ncbi.nlm.nih.gov/pubmed/29284819
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_21_17
_version_ 1783286899521093632
author Chepure, Ashish Hanmantrao
Ungratwar, Apurva Karmveer
author_facet Chepure, Ashish Hanmantrao
Ungratwar, Apurva Karmveer
author_sort Chepure, Ashish Hanmantrao
collection PubMed
description Olanzapine is a second-generation antipsychotic drug mainly used in the treatment of schizophrenia. It has several side effects including weight gain, hypercholesterolemia, and hyperglycemia, but dermatological side effects are rarely reported. We report a rare case of olanzapine-induced psoriasis.
format Online
Article
Text
id pubmed-5733436
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-57334362017-12-28 Olanzapine-induced Psoriasis Chepure, Ashish Hanmantrao Ungratwar, Apurva Karmveer Indian J Psychol Med Case Report Olanzapine is a second-generation antipsychotic drug mainly used in the treatment of schizophrenia. It has several side effects including weight gain, hypercholesterolemia, and hyperglycemia, but dermatological side effects are rarely reported. We report a rare case of olanzapine-induced psoriasis. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5733436/ /pubmed/29284819 http://dx.doi.org/10.4103/IJPSYM.IJPSYM_21_17 Text en Copyright: © 2017 Indian Psychiatric Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Chepure, Ashish Hanmantrao
Ungratwar, Apurva Karmveer
Olanzapine-induced Psoriasis
title Olanzapine-induced Psoriasis
title_full Olanzapine-induced Psoriasis
title_fullStr Olanzapine-induced Psoriasis
title_full_unstemmed Olanzapine-induced Psoriasis
title_short Olanzapine-induced Psoriasis
title_sort olanzapine-induced psoriasis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733436/
https://www.ncbi.nlm.nih.gov/pubmed/29284819
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_21_17
work_keys_str_mv AT chepureashishhanmantrao olanzapineinducedpsoriasis
AT ungratwarapurvakarmveer olanzapineinducedpsoriasis

Ejemplares similares